Dernièrement…

Welcome @AmoebaNature as a featured exhibitor at the BioSolutions Conference & Expo!

Amoéba is an innovative #greentech company providing the industry with disruptive & sustainable solutions for key resource treatment. Learn more at http://ow.ly/icPi50Mzv8N

#BioSolutions

📣 Communiqué de presse : https://bit.ly/3RbfQHe
#Amoéba annonce l’annulation de l’émission de la 8° tranche optionnelle d’OCA et la signature d’un contrat avec Redbridge Debt and Treasury Advisory afin d’adapter sa stratégie financière aux enjeux de transformation industrielle

📣 Communiqué de presse : https://bit.ly/3X2hdKt
#Amoéba confirme son éligibilité au dispositif PEA-PME. Les #actions AMOEBA peuvent donc être intégrées dans les portefeuilles PEA PME, dédiés aux #investissements dans les #PME et #ETI selon les critères réglementaires.

🎥 @Fabrice Plasson, PDG d’#Amoéba, revient sur cette année exceptionnelle dans une vidéo dédiée au #bilan 2022 et aux #perspectives 2023. AMM, nouvelle usine, stratégie, plan de financement, tant de sujets abordés sur la chaîne #YouTube d’#Amoéba : https://bit.ly/3Wz75bz

Development and commercialization agreement

Amoéba announces the signature of a Letter of Intent (LOI) with PHILAGRO France, concerning the development and marketing of its biocontrol product against vine downy mildew in France.
This signature, with a recognised player in the crop protection market, an entity born from the strategic alliance of three Japanese groups (SUMITOMO Chemical Company, NISSAN Chemical Industries and NIHON NOHYAKU Company), follows on from the partnership announced in April 2020 to evaluate the performance of the biocontrol fungicide containing AMOEBA’s active substance: the amoeba lysate Willaertia magna C2c Maky.
The aim of the LOI is to define the collaboration outlines between the two companies before and after the marketing of the product on the French territory with a view to signing a commercial partnership contract within 12 months.
Amoéba will carry out the regulatory tests necessary for the registration of its product and PHILAGRO will refine the marketing and commercial positioning of the product through field trials.
Amoéba has made an exclusive commitment with PHILAGRO France concerning vine application over a marketing period of several years in France, the leading European market for downy mildew treatment.
“The Philagro team is delighted to be able to work with Amoéba for the development and future marketing of this very promising biocontrol solution in the strategic segment of the vine downy mildew. The two companies share a common vision of the evolution of the French market and high expectations in biocontrol innovations, complementing each other perfectly to make this solution a real technical and commercial success” explains Denis TROALEN, General Manager of PHILAGRO France.
“The choice of PHILAGRO as an exclusive partner is guided by more than 25 years of experience in the service of crop protection, a strong operational positioning in biocontrol and a real capacity for commercial execution in this strategic segment. The human relationship established between our two companies during this 2020 year of field tests has convinced us of the unfailing motivation of the teams to make the most of our product against vine downy mildew in France. “comments Fabrice PLASSON, Chairman and CEO of Amoéba.